DiaMedica Therapeutics Inc.
DMAC
$5.42
-$0.19-3.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.04M | -8.74M | -8.62M | -7.70M | -7.71M |
| Total Depreciation and Amortization | 11.00K | 11.00K | 18.00K | 3.00K | 11.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 654.00K | 961.00K | 788.00K | 611.00K | 626.00K |
| Change in Net Operating Assets | 295.00K | 3.00K | 1.26M | -513.00K | -79.00K |
| Cash from Operations | -9.08M | -7.77M | -6.55M | -7.60M | -7.15M |
| Capital Expenditure | -8.00K | -6.00K | -16.00K | -6.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.11M | 8.00M | -25.75M | 8.96M | 6.63M |
| Cash from Investing | -2.11M | 8.00M | -25.77M | 8.96M | 6.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.00K | -2.00K | -3.00K | -2.00K | -3.00K |
| Issuance of Common Stock | 420.00K | 12.04M | 31.99M | 163.00K | 94.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 56.00K | -456.00K | -- | -- |
| Cash from Financing | 417.00K | 12.09M | 31.53M | 161.00K | 91.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.78M | 12.32M | -783.00K | 1.52M | -436.00K |